中文名 | SuberoylBis-hydroxamicAcid |
英文名 | SuberoylBis-hydroxamicAcid |
别名 | 软木肟酸 次异羟肟酸 辛烷-1,8-二氧肟酸 N1,N8-二羟基辛烷二酰胺 |
英文别名 | ODHA SBHA STAT3 (PTYR705) [PTYR705]-STAT3 SUBEROHYDROXAMIC ACID Suberohydroxamic acid SUBERIC BISHYDROXAMATE SuberoylBis-hydroxamicAcid SUBEROYL BISHYDROXAMIC ACID OCTANE-1,8-DIHYDROXAMIC ACID |
CAS | 38937-66-5 |
化学式 | C8H16N2O4 |
分子量 | 204.22 |
熔点 | 153-155°C(lit.) |
溶解度 | H2O: 可溶 |
存储条件 | −20°C |
稳定性 | 吸湿性 |
外观 | 冻干粉 |
颜色 | White to Light Beige |
MDL号 | MFCD00192455 |
体外研究 | Suberoyl bis-hydroxamic acid (10, 20 or 50 μM; 24 hours) combination with TRAIL improves apoptosis extent, and when TRAIL is combined with 20 μM SBHA (itself causing only 10–15% apoptosis), resulting in 45–50% cell death.Suberoyl bis-hydroxamic acid (20-50 μM; 10-20 hours) alone has little effect on the expression of the proteins Bcl-xL, Mcl-1, and has albeit mildeffect on Bax. When it combines with TRAIL,which increases the ratio of relative protein expression of Bcl-xL and Bax in early periods, while the change in the ratio of Mcl-1 and Bax increases later in MM-BI and Ist-Mes2 cells.Suberoyl bis-hydroxamic acid (30 μM; 6 hours) causes accumulation of acetylated histone H4 in MEL cells. Apoptosis Analysis Cell Line: MM-BI and Ist-Mes2 cells Concentration: 10 μM, 20 μM or 50 μM Incubation Time: 24 hours Result: Showed a cooperative effect in cell apoptosis. |
体内研究 | Suberoyl bis-hydroxamic acid (intraperitoneal injection; 200 mg/kg; every 2 days; 12 days) reveals a marked increase in the active form of Notch1 (NICD) with a concomitant decrease in ASCL1. It reduces the MTC tumor growth. Animal Model: Nude mice injected with human MTC cells Dosage: 200 mg/kg Administration: Intraperitoneal injection; every 2 days; 12 days Result: Resulted in an average 55% inhibition of tumor growth in SBHA treatment group. |
安全术语 | S22 - 切勿吸入粉尘。 S24/25 - 避免与皮肤和眼睛接触。 |
WGK Germany | 3 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!